Korro Bio, Inc. — Director's Dealing 2023

Jul 13, 2023

SEC Form 4/A — Form 4/A

Issuer: Frequency Therapeutics, Inc. (FREQ)
CIK: 0001703647
Period of Report: 2023-07-04

Reporting Person: Mitrano Richard J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-04	Common Stock	M	25000	—	Acquired	55995	Direct
2023-07-06	Common Stock	S	224	$0.35	Disposed	55771	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-04	Restricted Stock Unit	$	M	25000	Disposed		Common Stock (25000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4032	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.

F3: The Restricted Stock Units vested on July 4, 2023 and do not have an expiration date.